Subscribe free

HPB & Spleen ·

Lymph Node Dissection on Intrahepatic Cholangiocarcinoma: Potential Benefit only for Clinically Node-Negative Patients

According to a systematic review and meta-analysis, researchers found that lymph node dissection (LND) did not significantly impact overall survival, disease-free survival, or risk of major complications in patients with intrahepatic cholangiocarcinoma (ICC). However, for clinically node-negative patients, LND was associated with improved overall survival and a trend towards improved disease-free survival compared to no LND. These findings suggest that LND may benefit a specific subgroup of ICC patients, but its overall impact on long-term survival and morbidity in ICC is still limited.

Review by Yeow M, Fong KY (…) Kabir T et 6 al. in HPB (Oxford)

Copyright © 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

read the whole article in HPB (Oxford)

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →